Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies - Anna R. Giuliano; Joel M. Palefsky; Stephen E. Goldstone; Jacob Bornstein; Ilse De Coster; Ana María Guevara; Ole Mogensen; SCHILLING REDLICH, ANDREA INGRID; Pierre Van Damme; Corinne Vandermeulen; Misoo C. Ellison; Susan Kaplan; et al. (Informa UK Limited, 2025)
Keywords: adolescent; adult; antibodies, viral; child; female; humans; immunogenicity, vaccine; male; papillomavirus infections; papillomavirus vaccines; young adult; human papilloma virus vaccine; vaccine; virus vaccine; human papilloma virus vaccine; virus antibody; adult; aged; article; blood donor; drug safety; female; gonorrhea; human; human papillomavirus type 45; human papillomavirus type 52; immunogenicity; major clinical study; male; papillomavirus infection; post hoc analysis; sexual orientation; vaccine immunogenicity; wart virus; adolescent; blood; child; clinical trial; controlled study; immunology; papillomavirus infection; phase 3 clinical trial; prevention and control; randomized controlled trial; vaccine immunogenicity; young adult